An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients
01 Pubblicazione su rivista
Aghdaei Ha, Kadijani Aa, Sorrentino D, Mirzaei A, Shahrokh S, Balaii H, Geraci M, Zali Mr
ISSN: 2050-6406